Short Communication: From wasting to obesity: Initial antiretroviral therapy and weight gain in HIV-infected persons

AIDS Research and Human Retroviruses

Volumn 29, Issue 3, 2013, Pages 435-440

  Lakey, Wanda ^a,b   Yang, Lan Yan ^c   Yancy, William ^a,b   Chow, Shein Chung ^c   Hicks, Charles ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT DURATION; WASTING SYNDROME; WEIGHT CHANGE; WEIGHT GAIN;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; WEIGHT GAIN; YOUNG ADULT;

EID: 84874487248     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0234     Document Type: Article

References (14)

1. Amorosa V, Synnestvedt M, Gross R, Freidman H, MacGregor RR, Gudonis D, Frank I, and Tebas P: A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005;39:557-561.
2. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, and Ganesan A: Obesity among patients with HIV: The latest epidemic. AIDS Patient Care STDs 2008;22:925-930.
3. NHLBI Obesity Education Initiative: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. NIH publication no. 98-4083. 1998; U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, M.D.
4. Klein D, Hurley LB, Quesenberry CP, and Sidney S: Do protease inhibitors increase the risk of coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002;30:471-477.
5. Currier JS, Taylor A, Boyd F, Dezil CM, Kawabata H, Burtcel B, Maa JF, and Hodder S: Coronary heart disease in HIVinfected individuals. J Acquir Immune Defic Syndr 2003; 33:506-512.
6. Friis-Moller N, Sabin CA, Weber R, D'Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, Morfeldt L, DeWit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, and Lundgren JD: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
7. Law MG, Friis-Moller N, El-Sadr WM, Weber R, Reiss P, D'Arminio Monforte A, Thiebaut R, Morfeldt L, DeWit S, Pradier C, Calvo G, Kirk O, Sabin CA, Phillips AN, and Lundgren JD: The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: Com-parison with observed events in the D:A:D study. HIV Med 2006;7:218-230.
8. Flegal KM, Carroll M, Ogden CL, and Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
9. Crum-Cianflone NF, Roediger M, Eberly LE, Headd M, Marconi V, Ganesan A, Weintrob A, Barthel RV, Fraser S, and Agan BK: Increasing rates of obesity among HIVinfected persons during the HIV epidemic. PLoS One 2010;5:e10106.
10. Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, Anastos K, Karim R, Hyman C, and Hershow RC: Prevalence and correlates of elevated body mass index among HIVpositive and HIV-negative women in theWomen's Interagency HIV Study. AIDS Patient Care STDs 2009;23:1009-1016.
11. Shikuma CM, Zackin R, Sattler F, Mildvan D, Nyangweso P, Alston S, Evans S, and Mulligan K: Changes in weight and lean body mass during highly active antiretroviral therapy. CID 2009;39:1223-1230.
12. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, and Campbell LV: Obesity is an important determinant of baseline serum C-reactive protein concentrations in monozygotic twins, independent of genetic influences. Circulation 2004;109:3022-3028.
13. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, and Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397.
14. Ross AC, Armentrout R, O'Riordan MA, Storer N, Rizk N, Harrill D, El Bejjani D, and McComsey GA: Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr 2008;49:499-506.